Not applicableStudy completedNCT07151508
What this trial is testing
Successful Treatment of Netherton Syndrome With Combination of Secukinumab and Dupilumab
Who this might be right for
Neterton Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15